We are pleased to announce that with the new MammaTyper® Test from BioNTech, we could expand our MDx portfolio in the field of breast cancer biomarker detection and quantification with an innovative Genexpression Test, which reliably quantifies the four recommended genes according to the St. Gallen guidelines. For the extraction and purification of total RNA
- info@buhlmannlabs.ch
- +41 61 487 12 12
News
After the innovative AmpliVue® POC Tests, we are pleased to announce that with the Lyra® Real-time PCR assays we have another interesting product line of Quidel® in our portfolio. To learn more about the Lyra®, Lyra® Direct and Lyra® Blu assays, click here.
Dear Visitors We are proud to announce the launch of the new BÜHLMANN website. In recent years more and more people are accessing the internet from laptops, tablets and smartphones. As a consequence customers are looking at websites on a different screen size. To reflect that change we specifically chose a design that looks fresh and
Interview with the leader of this evaluation study, Marie-Christine Descombes about her positive experiences with this new rapid MDx testing system to detect HSV1 and HSV2 directly from swab samples in 60 minutes with less than 10 minutes Hands-On time. Click here.
Social Links